ACE and Duchenne muscular dystrophy: The DMD care guidelines 2018 suggested the use of CMRI for early detection of DMD-related cardiomyopathy and initiation of angiotensin-converting enzyme (ACE) inhibitors in boys > 10 years of age or those who have cardiac dysfunction in the investigations (8).